Recent Media Coverage

A Review of the Trans-Atlantic Divide on Drug Prices Between the United States and the United Kingdom

One of the largest groups for doctors in the U.S. is calling for new health care oversight in an effort to counter high prescription drug costs.

Internal document seen by the Guardian shows low supplies for heart, cancer and anti-epilepsy drugs.

As part of the conversation on options for universal pharmacare in Canada, The Conference Board of Canada examined patients’ access to necessary diabetes medications.

In medicine, spending more is not always better.

A West Island woman living with cystic fibrosis says the prohibitive price of a drug is costing Canadian lives.

Speaker Nancy Pelosi and a host of both Democrats and Republicans want the federal government to apply price controls to prescription drugs. Their proposals are based on two fantasies.

We should override patent protection on some medicines and change how R&D is funded.

Donald Trump wants the big US pharmaceutical companies to get its hands on our public services – and the Conservatives are conniving to help the sell-off.

Mr Corbyn is expected to confirm a pledge to force pharmaceutical companies to give up exclusive rights to produce drugs that they have developed themselves, in cases where the government decides that existing prices are too high.

A Look at ICER’s Unsupported Drug Price Increase Report

Two regulations advance the Trump Administration’s commitment to increasing price transparency.